{"transactions":[{"id":733274,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2026-06-17T23:06:45.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":12555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":12555,"derivative":{"exercise_price":0.7293,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":12555},"source":{"system":"sec-edgar","filing":"0001104659-26-075283","document":"tm2618211-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1697628/000110465926075283/tm2618211-6_4seq1.xml","form_type":"4"}},{"id":733273,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-17T23:06:45.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":3135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units which were granted on June 16, 2026, and which will vest and be settled in common stock on June 16, 2027, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":6254,"source":{"system":"sec-edgar","filing":"0001104659-26-075283","document":"tm2618211-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697628/000110465926075283/tm2618211-6_4seq1.xml","form_type":"4"}},{"id":822484,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Warrant","published_at":"2026-04-01T20:15:17.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":123915,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 30, 2026, the Issuer entered into a securities purchase agreement (the \"Purchase Agreement\") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement which closed on March 31, 2026, (i) pre-funded warrants (\"Pre-Funded Warrants\") to purchase up to an aggregate of 123,915 shares of the Issuer's common stock (\"Shares\") at a purchase price of $0.808, less the $0.001 exercise price, per Pre-Funded Warrant and (ii) accompanying common warrants (\"Common Warrants\") to purchase up to an aggregate of 123,915 Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 30, 2026, the Issuer entered into a securities purchase agreement (the \"Purchase Agreement\") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement which closed on March 31, 2026, (i) pre-funded warrants (\"Pre-Funded Warrants\") to purchase up to an aggregate of 123,915 shares of the Issuer's common stock (\"Shares\") at a purchase price of $0.808, less the $0.001 exercise price, per Pre-Funded Warrant and (ii) accompanying common warrants (\"Common Warrants\") to purchase up to an aggregate of 123,915 Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Common Warrants are immediately exercisable, subject to the Beneficial Ownership Limitation. The Common Warrants will expire on the earlier of (ii) December 31, 2029, and (ii) 30 calendars days after the date upon which the Pre-Funded Warrant is exercised, proportional to the amount of such exercise."}],"balance_after":123915,"derivative":{"exercise_price":0.683,"exercise_date":"2026-03-31","underlying":"Common Stock","underlying_shares":123915},"source":{"system":"sec-edgar","filing":"0001104659-26-038518","document":"tm2610878-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1697628/000110465926038518/tm2610878-1_4seq1.xml","form_type":"4"}},{"id":822483,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Pre-Funded Warrant","published_at":"2026-04-01T20:15:17.000Z","date":"2026-03-31","kind":"purchase","planned":false,"acquired":true,"shares":123915,"price":0.807,"value":99999.405,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 30, 2026, the Issuer entered into a securities purchase agreement (the \"Purchase Agreement\") with certain accredited investors, including the Reporting Person. Pursuant to the terms of the Purchase Agreement, the Issuer issued and sold to the Reporting Person in a private placement which closed on March 31, 2026, (i) pre-funded warrants (\"Pre-Funded Warrants\") to purchase up to an aggregate of 123,915 shares of the Issuer's common stock (\"Shares\") at a purchase price of $0.808, less the $0.001 exercise price, per Pre-Funded Warrant and (ii) accompanying common warrants (\"Common Warrants\") to purchase up to an aggregate of 123,915 Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Pre-Funded Warrants are immediately exercisable at any time after the date of issuance. Pursuant to the terms of the Pre-Funded Warrants, the Pre-Funded Warrants cannot be exercised to the extent that, upon giving effect to or immediately prior to such exercise, would cause either (i) the aggregate number of shares of Common Stock beneficially owned by such holder (together with its affiliates) would exceed 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to such exercise or (ii) the combined voting power of the Issuer's securities beneficially owned by such holder (together with its affiliates) would exceed 9.99% of the combined voting power of all of the Issuer's securities outstanding immediately after giving effect to the exercise (the \"Beneficial Ownership Limitation\")"}],"balance_after":123915,"derivative":{"exercise_price":0.001,"exercise_date":"2026-03-31","underlying":"Common Stock","underlying_shares":123915},"source":{"system":"sec-edgar","filing":"0001104659-26-038518","document":"tm2610878-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697628/000110465926038518/tm2610878-1_4seq1.xml","form_type":"4"}},{"id":1094993,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T16:26:05.000Z","date":"2025-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of December 11, 2024, by and among TuHURA Biosciences, Inc. (\"TuHURA\"), Hura Merger Sub I, Inc., a Delaware corporation and a direct wholly-owned subsidiary of TuHURA (\"Merger Sub I\"), Hura Merger Sub II, LLC, a Delaware limited liability company and direct wholly-owned subsidiary of TuHURA (\"Merger Sub II,\") and together with Merger Sub I, the \"Merger Subs\"), Kineta, Inc., a Delaware corporation (\"Kineta\") and Craig Philips, solely in his capacity as the representative, agent and attorney-in-fact of the stockholders of Kineta, and as amended by that certain First Amendment to Agreement and Plan of Merger, dated May 5, 2025 (as amended, the \"Merger Agreement\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This footnote is a continuation of footnote 1 above. Pursuant to the Merger Agreement, (i) Merger Sub I merged with and into Kineta (the \"First Merger\"), with Kineta surviving the First Merger as a wholly-owned subsidiary of TuHURA (the \"Surviving Corporation\"), and (ii) the Surviving Corporation merged with and into Merger Sub II (the \"Second Merger\" and together with the First Merger, the \"Mergers\"), with Merger Sub II surviving the Second Merger as a wholly-owned subsidiary of TuHURA."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each option to purchase shares of the Kineta Common Stock that was outstanding immediately prior to the Effective Time that had an exercise price per share greater than $0.64 was canceled and extinguished for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"At the Effective Time, each option to purchase shares of the Kineta Common Stock that was outstanding immediately prior to the Effective Time that had an exercise price per share greater than $0.64 was canceled and extinguished for no consideration."}],"balance_after":0,"derivative":{"exercise_price":3.28,"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-25-093015","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000095017025093015/ownership.xml","form_type":"4"}},{"id":1094992,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-02T16:26:05.000Z","date":"2025-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of December 11, 2024, by and among TuHURA Biosciences, Inc. (\"TuHURA\"), Hura Merger Sub I, Inc., a Delaware corporation and a direct wholly-owned subsidiary of TuHURA (\"Merger Sub I\"), Hura Merger Sub II, LLC, a Delaware limited liability company and direct wholly-owned subsidiary of TuHURA (\"Merger Sub II,\") and together with Merger Sub I, the \"Merger Subs\"), Kineta, Inc., a Delaware corporation (\"Kineta\") and Craig Philips, solely in his capacity as the representative, agent and attorney-in-fact of the stockholders of Kineta, and as amended by that certain First Amendment to Agreement and Plan of Merger, dated May 5, 2025 (as amended, the \"Merger Agreement\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This footnote is a continuation of footnote 1 above. Pursuant to the Merger Agreement, (i) Merger Sub I merged with and into Kineta (the \"First Merger\"), with Kineta surviving the First Merger as a wholly-owned subsidiary of TuHURA (the \"Surviving Corporation\"), and (ii) the Surviving Corporation merged with and into Merger Sub II (the \"Second Merger\" and together with the First Merger, the \"Mergers\"), with Merger Sub II surviving the Second Merger as a wholly-owned subsidiary of TuHURA."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each option to purchase shares of the Kineta Common Stock that was outstanding immediately prior to the Effective Time that had an exercise price per share greater than $0.64 was canceled and extinguished for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"At the Effective Time, each option to purchase shares of the Kineta Common Stock that was outstanding immediately prior to the Effective Time that had an exercise price per share greater than $0.64 was canceled and extinguished for no consideration."}],"balance_after":0,"derivative":{"exercise_price":3.28,"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-25-093015","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000095017025093015/ownership.xml","form_type":"4"}},{"id":1094991,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T16:26:05.000Z","date":"2025-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":101891,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger, dated as of December 11, 2024, by and among TuHURA Biosciences, Inc. (\"TuHURA\"), Hura Merger Sub I, Inc., a Delaware corporation and a direct wholly-owned subsidiary of TuHURA (\"Merger Sub I\"), Hura Merger Sub II, LLC, a Delaware limited liability company and direct wholly-owned subsidiary of TuHURA (\"Merger Sub II,\") and together with Merger Sub I, the \"Merger Subs\"), Kineta, Inc., a Delaware corporation (\"Kineta\") and Craig Philips, solely in his capacity as the representative, agent and attorney-in-fact of the stockholders of Kineta, and as amended by that certain First Amendment to Agreement and Plan of Merger, dated May 5, 2025 (as amended, the \"Merger Agreement\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This footnote is a continuation of footnote 1 above. Pursuant to the Merger Agreement, (i) Merger Sub I merged with and into Kineta (the \"First Merger\"), with Kineta surviving the First Merger as a wholly-owned subsidiary of TuHURA (the \"Surviving Corporation\"), and (ii) the Surviving Corporation merged with and into Merger Sub II (the \"Second Merger\" and together with the First Merger, the \"Mergers\"), with Merger Sub II surviving the Second Merger as a wholly-owned subsidiary of TuHURA."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the First Merger (the \"Effective Time\"), each one (1) issued and outstanding share of Kineta's common stock, par value $0.001 per share (\"Kineta Common Stock\"), was cancelled and converted into the right to receive 0.185298 share of common stock of TuHURA, par value $0.001 per share (\"TuHURA Common Stock\"). Also pursuant to the Merger Agreement, each one (1) share of Kineta Common Stock is also entitled to (i) its pro rata portion of 1,129,884 shares of TuHURA Common Stock to be issued six months following the closing of the Mergers, subject to adjustment for losses incurred or accrued during the six month period from the closing of the Mergers, and (ii) the right to its pro rata share of cash consideration received by Kineta pursuant to disposed asset payments related to legacy Kineta assets."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-093015","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000095017025093015/ownership.xml","form_type":"4"}},{"id":1101667,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-25T21:54:47.000Z","date":"2025-06-23","kind":"exercise","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the terms of (i) the Optionholder Treatment Agreement, dated June 16, 2025, by and between Kineta, Inc. (the \"Company\") and the Reporting Person, and (ii) the Agreement and Plan of Merger, dated as of December 11, 2024, by and among the Company, TuHURA Biosciences, Inc., a Nevada corporation (\"TuHURA\"), Hura Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of TuHURA, Hura Merger Sub II, a Delaware limited liability company and a wholly owned subsidiary of TuHURA, and Craig Philips, as representative of the stockholders of the Company, and as amended by that certain First Amendment to Agreement and Plan of Merger, dated May 5, 2025, as approved by the Company's stockholders at the Special Meeting of Stockholders held on June 23, 2025, the options granted to the Reporting Person under the 2022 Equity Incentive Plan became fully vested on June 23, 2025."}],"balance_after":0,"derivative":{"exercise_price":0.611,"expiration_date":"2034-09-03","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-25-090144","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000095017025090144/ownership.xml","form_type":"4"}},{"id":1101666,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-25T21:54:47.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":101891,"source":{"system":"sec-edgar","filing":"0000950170-25-090144","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000095017025090144/ownership.xml","form_type":"4"}},{"id":1101665,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-25T21:54:47.000Z","date":"2025-06-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":4706,"price":0.26,"value":1223.56,"ownership":{"direct":true},"balance_after":95891,"source":{"system":"sec-edgar","filing":"0000950170-25-090144","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000095017025090144/ownership.xml","form_type":"4"}},{"id":1101664,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-25T21:54:47.000Z","date":"2025-06-23","kind":"exercise","planned":false,"acquired":true,"shares":12500,"price":0.611,"value":7637.5,"ownership":{"direct":true},"balance_after":100597,"source":{"system":"sec-edgar","filing":"0000950170-25-090144","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000095017025090144/ownership.xml","form_type":"4"}},{"id":1117339,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-09T20:06:53.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":4185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":4185,"derivative":{"exercise_price":1.81,"expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":4185},"source":{"system":"sec-edgar","filing":"0001104659-25-057821","document":"tm2517366-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1697628/000110465925057821/tm2517366-7_4seq1.xml","form_type":"4"}},{"id":1117338,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-09T20:06:53.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":1045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units which were granted on June 5, 2025, and which will vest and be settled in common stock on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":3119,"source":{"system":"sec-edgar","filing":"0001104659-25-057821","document":"tm2517366-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697628/000110465925057821/tm2517366-7_4seq1.xml","form_type":"4"}},{"id":1413797,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-05T16:21:48.000Z","date":"2024-09-04","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest in equal quarterly installments over one year following June 21, 2024, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":12500,"derivative":{"exercise_price":0.611,"expiration_date":"2034-09-03","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-24-104023","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000095017024104023/ownership.xml","form_type":"4"}},{"id":1471664,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-06-21T20:18:13.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":4185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on June 20, 2025, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":4185,"derivative":{"exercise_price":4.07,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":4185},"source":{"system":"sec-edgar","filing":"0001104659-24-073943","document":"tm2417666-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1697628/000110465924073943/tm2417666-4_4seq1.xml","form_type":"4"}},{"id":1471663,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-21T20:18:13.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":1045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units which were granted on June 20, 2024, and which will vest and be settled in common stock on June 20, 2025, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":2074,"source":{"system":"sec-edgar","filing":"0001104659-24-073943","document":"tm2417666-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697628/000110465924073943/tm2417666-4_4seq1.xml","form_type":"4"}},{"id":1797375,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-08-25T01:50:45.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on August 23, 2024, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":2000,"derivative":{"exercise_price":3.65,"expiration_date":"2033-08-23","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001104659-23-095018","document":"tm2324788-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1697628/000110465923095018/tm2324788-5_4seq1.xml","form_type":"4"}},{"id":1797374,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-25T01:50:45.000Z","date":"2023-08-23","kind":"grant","planned":false,"acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units which were granted on August 23, 2023, and which will vest and be settled in common stock on August 23, 2024, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":1029,"source":{"system":"sec-edgar","filing":"0001104659-23-095018","document":"tm2324788-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697628/000110465923095018/tm2324788-5_4seq1.xml","form_type":"4"}},{"id":1919524,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-14T16:11:30.000Z","date":"2023-04-12","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest as to 1/12 of the total number of shares on July 7, 2023 and each monthly anniversary thereafter, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":12500,"derivative":{"exercise_price":3.28,"expiration_date":"2033-04-11","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-23-024300","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000120919123024300/doc4.xml","form_type":"4"}},{"id":1919523,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-14T16:11:30.000Z","date":"2023-04-12","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vested and continues to vest as to 1/36 of the total number of shares on February 1, 2023 and on each monthly anniversary thereafter, subject to the continuing service of the Reporting Person on each vesting date."}],"balance_after":20000,"derivative":{"exercise_price":3.28,"expiration_date":"2033-04-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-23-024300","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000120919123024300/doc4.xml","form_type":"4"}},{"id":2079704,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-20T20:59:14.000Z","date":"2022-12-16","kind":"tax_withholding","acquired":false,"shares":1931,"price":1.86,"value":3591.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld by the Company in payment of the withholding tax liability incurred upon settlement of restricted stock units previously awarded. The amount of shares withheld is based on the closing sale price on December 16, 2022."}],"balance_after":88097,"source":{"system":"sec-edgar","filing":"0001209191-22-062282","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000120919122062282/doc4.xml","form_type":"4"}},{"id":2094394,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-12-06T16:56:09.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":10890,"price":1.6913,"value":18418.257,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of shares of restricted stock granted to the Reporting Person. This sale is mandated by the Issuer, Yumanity Therapeutics, Inc., to satisfy tax withholding obligations by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69 to $1.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":90028,"source":{"system":"sec-edgar","filing":"0000899243-22-037790","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000089924322037790/doc4.xml","form_type":"4"}},{"id":2198799,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to Buy)","published_at":"2022-08-01T21:05:29.000Z","date":"2022-07-28","kind":"grant","acquired":true,"shares":29575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the\napplicable vesting date and subject to acceleration under certain conditions."}],"balance_after":29575,"derivative":{"exercise_price":1.09,"expiration_date":"2032-07-28","underlying":"Common Stock","underlying_shares":29575},"source":{"system":"sec-edgar","filing":"0001104659-22-084770","document":"tm2222147-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1697628/000110465922084770/tm2222147-8_4seq1.xml","form_type":"4"}},{"id":2198798,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-01T21:05:29.000Z","date":"2022-07-28","kind":"grant","acquired":true,"shares":5995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units which were granted on July 28, 2022, and which will vest and be settled in common stock on July 28, 2023,\nsubject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to\nacceleration under certain conditions."}],"balance_after":10605,"source":{"system":"sec-edgar","filing":"0001104659-22-084770","document":"tm2222147-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697628/000110465922084770/tm2222147-8_4seq1.xml","form_type":"4"}},{"id":2211797,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-07-06T16:54:10.000Z","date":"2022-07-05","kind":"sale","acquired":false,"shares":4584,"price":1.8491,"value":8476.2744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units granted to the Reporting Person. This sale is mandated by the Issuer, Yumanity Therapeutics, Inc., to satisfy tax withholding obligations by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.84 to $1.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":100918,"source":{"system":"sec-edgar","filing":"0000899243-22-025399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000089924322025399/doc4.xml","form_type":"4"}},{"id":2242228,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-06-06T21:45:03.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":10206,"price":1.1946,"value":12192.0876,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of shares of restricted stock granted to the Reporting Person. This sale is mandated by the Issuer, Yumanity Therapeutics, Inc., to satisfy tax withholding obligations by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.14 to $1.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":105502,"source":{"system":"sec-edgar","filing":"0000899243-22-021283","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000089924322021283/doc4.xml","form_type":"4"}},{"id":2314260,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-30T16:05:14.000Z","date":"2022-03-28","kind":"sale","acquired":false,"shares":10715,"price":1.8455,"value":19774.5325,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":115708,"source":{"system":"sec-edgar","filing":"0000899243-22-012782","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000089924322012782/doc4.xml","form_type":"4"}},{"id":2485659,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-12-03T16:15:21.000Z","date":"2021-12-01","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award granted under the Yumanity Therapeutics, Inc. Amended and Restated 2018 Stock Option and Grant Plan. Fifty percent of the shares subject to the award will vest six months after the grant date and fifty percent will vest twelve months after the grant date, provided that the award recipient continues to have a service relationship with the Company at such time."}],"balance_after":126423,"source":{"system":"sec-edgar","filing":"0000899243-21-046760","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000089924321046760/doc4.xml","form_type":"4"}},{"id":2639280,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-07T16:44:43.000Z","date":"2021-07-06","kind":"tax_withholding","acquired":false,"shares":79,"price":10.79,"value":852.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs granted to the Reporting Person. This sale is mandated by the Issuer, Yumanity Therapeutics, Inc., to satisfy tax withholding obligations by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."}],"balance_after":56423,"source":{"system":"sec-edgar","filing":"0000899243-21-027794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000089924321027794/doc4.xml","form_type":"4"}},{"id":2639279,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-07-07T16:44:43.000Z","date":"2021-07-02","kind":"tax_withholding","acquired":false,"shares":4441,"price":11.11,"value":49339.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs granted to the Reporting Person. This sale is mandated by the Issuer, Yumanity Therapeutics, Inc., to satisfy tax withholding obligations by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.104182 to $11.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":56502,"source":{"system":"sec-edgar","filing":"0000899243-21-027794","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000089924321027794/doc4.xml","form_type":"4"}},{"id":2647079,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T23:02:25.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":22750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on June 30, 2022, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":22750,"derivative":{"exercise_price":4.88,"expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":22750},"source":{"system":"sec-edgar","filing":"0001567619-21-012873","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1697628/000156761921012873/doc1.xml","form_type":"4"}},{"id":2647078,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T23:02:25.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":4610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units which were granted on June 30, 2021, and which will vest and be settled in common stock on June 30, 2022, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":4610,"source":{"system":"sec-edgar","filing":"0001567619-21-012873","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697628/000156761921012873/doc1.xml","form_type":"4"}},{"id":2881593,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-03T18:42:12.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":60944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest and become exercisable in 48 equal monthly installments over four years following July 1, 2020."}],"balance_after":60944,"derivative":{"exercise_price":17.89,"expiration_date":"2031-01-31","underlying":"Common Stock","underlying_shares":60944},"source":{"system":"sec-edgar","filing":"0000899243-21-004749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000089924321004749/doc4.xml","form_type":"4"}},{"id":2881592,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-03T18:42:12.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable in 48 equal monthly installments over four years following the Grant Date."}],"balance_after":120000,"derivative":{"exercise_price":17.89,"expiration_date":"2031-01-31","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000899243-21-004749","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000089924321004749/doc4.xml","form_type":"4"}},{"id":2881591,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-02-03T18:42:12.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":60943,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported in this transaction represent Restricted Stock Units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest in four equal annual installments over four years following July 1, 2020."}],"balance_after":60943,"source":{"system":"sec-edgar","filing":"0000899243-21-004749","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000089924321004749/doc4.xml","form_type":"4"}},{"id":2931231,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-12-28T19:14:28.000Z","date":"2020-12-22","kind":"grant","acquired":true,"shares":235237,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On August 22, 2020, the Issuer (formerly known as Proteostasis Therapeutics, Inc.) entered into an Agreement and Plan of Merger and Reorganization, as amended on November 6, 2020, with Pangolin Merger Sub, Inc. (\"Merger Sub\"), Yumanity, Inc. (formerly known as Yumanity Therapeutics, Inc.) and Yumanity Holdings, LLC (\"Holdings\"). On December 22, 2020, Merger Sub was merged with and into Yumanity, Inc., with Yumanity, Inc. surviving as a wholly-owned subsidiary of the Issuer (the \"Merger\").  Immediately prior to the consummation of the Merger, Holdings was merged with and into Yumanity, Inc., with Yumanity, Inc. as the surviving entity."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received in the Merger in exchange for a stock option to acquire 1,115,708 shares of Yumanity, Inc. common stock for $1.72 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vested on July 10, 2020.  The remaining 75% vest in equal monthly installments over the subsequent three years."}],"balance_after":235237,"derivative":{"exercise_price":8.16,"expiration_date":"2029-09-08","underlying":"Common Stock","underlying_shares":235237},"source":{"system":"sec-edgar","filing":"0000899243-20-035276","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1445283/000089924320035276/doc4.xml","form_type":"4"}},{"id":3097373,"issuer":{"id":7948,"kind":"organization","name":"Aprea Therapeutics, Inc."},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true}}],"security":"Stock Option (right to Buy)","published_at":"2020-06-29T22:04:54.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on June 26, 2021 subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions."}],"balance_after":7000,"derivative":{"exercise_price":38.32,"expiration_date":"2030-06-26","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0000905148-20-000732","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1697628/000090514820000732/form4.xml","form_type":"4"}},{"id":3531301,"issuer":{"id":95770,"kind":"organization","name":"MERRIMACK PHARMACEUTICALS INC","symbol":"MACK"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-05-10T07:39:26.000Z","date":"2019-05-08","kind":"other","acquired":false,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"An option to purchase 225,000 shares was originally granted to the Reporting Person on December 11, 2018. This option was rescinded in full on May 8, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The original vesting schedule for this option was 1/12th of the total number of shares granted on 3/11/19 and an additional 1/12th of the total number of shares granted at the end of each successive three month period thereafter until 12/11/21."}],"balance_after":0,"derivative":{"exercise_price":4.15,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-19-028674","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1274792/000120919119028674/doc4.xml","form_type":"4"}},{"id":3531300,"issuer":{"id":95770,"kind":"organization","name":"MERRIMACK PHARMACEUTICALS INC","symbol":"MACK"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2019-05-10T07:39:26.000Z","date":"2019-05-08","kind":"other","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"An option to purchase 225,000 shares was originally granted to the Reporting Person on February 15, 2018. 25,000 shares underlying this option were rescinded on May 8, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vested as to 1/12th of the total number of shares originally granted on 5/15/18 and an additional 1/12th of the total number of shares originally granted at the end of each successive three month period thereafter until 2/15/21."}],"balance_after":200000,"derivative":{"exercise_price":10.74,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-028674","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274792/000120919119028674/doc4.xml","form_type":"4"}},{"id":3732003,"issuer":{"id":95770,"kind":"organization","name":"MERRIMACK PHARMACEUTICALS INC","symbol":"MACK"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-12-13T16:18:38.000Z","date":"2018-12-11","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 1/12th of the total number of shares granted on 3/11/19 and an additional 1/12th of the total number of shares granted at the end of each successive three month period thereafter until 12/11/21."}],"balance_after":225000,"derivative":{"exercise_price":4.15,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-18-062438","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274792/000120919118062438/doc4.xml","form_type":"4"}},{"id":4051606,"issuer":{"id":95770,"kind":"organization","name":"MERRIMACK PHARMACEUTICALS INC","symbol":"MACK"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-16T16:09:57.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 1/12th of the total number of shares granted on 5/15/18 and an additional 1/12th of the total number of shares granted at the end of each successive three month period thereafter until 2/15/21."}],"balance_after":225000,"derivative":{"exercise_price":10.74,"expiration_date":"2028-02-14","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-18-010816","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274792/000120919118010816/doc4.xml","form_type":"4"}},{"id":4289659,"issuer":{"id":95770,"kind":"organization","name":"MERRIMACK PHARMACEUTICALS INC","symbol":"MACK"},"owners":[{"id":37112,"kind":"person","name":"Peters Richard","position":1,"cik":"0001697628","reported_name":"Peters Richard","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-07T16:45:53.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 1/4th of the total number of shares granted on 2/6/18 and an additional 1/16th of the total number of shares granted at the end of each successive three month period thereafter until 2/6/21."}],"balance_after":2000000,"derivative":{"exercise_price":1.45,"expiration_date":"2027-06-05","underlying":"Common Stock","underlying_shares":2000000},"source":{"system":"sec-edgar","filing":"0001209191-17-038322","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1274792/000120919117038322/doc4.xml","form_type":"4"}}]}